The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients

E. Jennifer Edelman, Tongtan Chantarat, Sarah Caffrey, Amina Chaudhry, Patrick G. O'Connor, Linda Weiss, David A. Fiellin, Lynn E. Fiellin

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds